Metastasis (spreading of cancer to other organs) is responsible for most cancer deaths, but the inability to model metastatic cancers has impeded efforts to develop treatments.
3D printing has been used to replicate a controlled cancer microenvironment in previous studies, but these studies didn’t achieve the level of realism necessary for drug screening.
“We need a much finer resolution than what a 3D printer can create,” Solorio commented.